Israel Defies AbbVie IP To Import Generic Drugs For COVID-19
Israel is allowing generic versions of AbbVie Inc.'s HIV drug Kaletra to be imported to treat coronavirus patients, even though the drug is still patent protected in the country, according to...To view the full article, register now.
Already a subscriber? Click here to view full article